A PYMNTS Company

US: Gilead to use White & Case for antitrust class action

By  |  June 19, 2019

White & Case has entered appearances for Gilead in Staley v. Gilead Sciences, while Arnold & Porter Kaye Scholer is representing Bristol-Myers Squibb; Drinker Biddle Reath represents Johnson & Johnson; and Holland & Knight reps Japan Tobacco.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Staley alleges that Gilead and the other drug companies have inflated the price of HIV medication through collusive licensing agreements, such as by combining Gilead compounds whose patents are expiring with other companies’ more recently patented compounds into fixed-dose combinations. The strategy is “crippling this nation’s ability to stop new HIV infections,” the plaintiffs contend in a May 14 complaint.

    Gilead has said that it enters into partnerships with other companies to create life-saving therapies. “Any suggestion that we had improper motives is absolutely false,” the company has said.

    Full Content: Law

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.